Different Healing Performance of Stem Cells in Heart Repair
Author Information
Author(s): Gaebel Ralf, Furlani Dario, Sorg Heiko, Polchow Bianca, Frank Johannes, Bieback Karen, Wang Weiwei, Klopsch Christian, Ong Lee-Lee, Li Wenzhong, Ma Nan, Steinhoff Gustav
Primary Institution: University of Rostock, Germany
Hypothesis
The study aims to assess the regenerative potential of human mesenchymal stem cells (hMSC) from different origins for the treatment of myocardial infarction.
Conclusion
hMSC from different sources exhibit varying healing performances in cardiac regeneration, with CD105+ hMSC showing better survival and cardiac function preservation.
Supporting Evidence
- BM and CD105+-CB treated groups showed significant preservation of left ventricular functions compared to CB and nontreated MI group.
- Cardiac remodeling was significantly attenuated by BM-hMSC compared to MI-C.
- Under hypoxic conditions, CB-hMSC showed increased apoptosis compared to BM and CD105 purified CB-derived hMSC.
Takeaway
This study found that stem cells from different places in the body can help heal the heart differently after a heart attack, and some types work better than others.
Methodology
Male SCID mice underwent LAD-ligation and received different types of hMSC intramyocardially, followed by assessments of cardiac function and tissue analysis six weeks post-infarction.
Potential Biases
Potential bias in the selection of stem cell sources and the experimental design.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Male SCID mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website